What happened with BTSG today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
BrightSpring Health Services serves older people and patients with complex medical needs, mainly in homes and community settings across the United States. Pharmacy services generate most of its revenue, led by infusion and specialty medicines that often require special handling, nursing support and help obtaining insurance coverage. It also supplies medications to senior-living communities, behavioral group homes and hospice patients. A smaller healthcare-services business provides home health, hospice, rehabilitation and help with daily living.
Medicare and Medicaid fund most of the revenue, with commercial insurance providing another important source. For outpatient prescriptions covered by Medicare Part D, BrightSpring primarily contracts with pharmacy benefit managers, which administer drug coverage and negotiate reimbursement. These include Caremark and Optum. Some healthcare facilities and other provider customers pay BrightSpring directly for pharmacy services.
The business depends on referrals from outside healthcare providers and on manufacturers granting access to specialty drugs with restricted distribution. Reimbursement rates and drug purchasing costs shape what it retains from sales. To receive Medicare payments, its facilities and agencies must meet participation requirements; payment also depends on satisfying applicable coverage, medical-necessity and documentation rules.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
BrightSpring’s results depend chiefly on specialty pharmacy prescription volumes and reimbursement, with Coram, Accredo and Optum Specialty Pharmacy also important competitors to watch.
Option Care Health competes with BrightSpring for patients receiving infusion drugs and clinical support outside hospitals, and for contracts with insurers and other healthcare payers. Watch its reimbursement for drugs and infusion services as a read on the payment conditions facing BrightSpring’s infusion business.
Humana both reimburses BrightSpring’s prescription services through contracts that manage drug benefits for health plans and competes with it in pharmacy and home-based care through CenterWell. Changes to Humana’s drug reimbursement rates or fees can directly affect BrightSpring’s pharmacy profitability.
Addus HomeCare competes with BrightSpring’s care-services business to provide daily-living assistance, home health and hospice to elderly and medically complex patients, with government agencies, insurers and individuals paying for its services. Its personal-care and home-health revenue offers a closer comparison for BrightSpring’s care business than for its much larger pharmacy business.
Aveanna Healthcare competes with BrightSpring in home health and hospice, but its business is more concentrated in private duty nursing. Watch its home-health admissions and revenue per completed Medicare episode—the patient volumes and payments most relevant to BrightSpring’s clinical home-care business.
Chemed’s VITAS competes with BrightSpring for hospice patients, but Chemed’s plumbing services for homes and businesses and BrightSpring’s large pharmacy business limit the overlap. VITAS’s hospice results are the relevant comparison, rather than Chemed’s combined results with Roto-Rooter.
Initial Jobless Claims (Oct/17)
Weekly jobless claims count new applications for unemployment benefits and signal how tight hiring conditions may be for the nurses, pharmacists, therapists and caregivers BrightSpring needs to deliver its services.
Expected200.0KLast release199.0K
If it comes in above expectations
If the reading is above the 200.0K estimate, it is above the previous 199.0K. More claims than expected may signal a weaker labor market and ease competition for BrightSpring’s care and pharmacy staff, potentially reducing wage pressure or making it easier to fill roles.
If it comes in below expectations
Fewer claims than expected may signal a firmer labor market and tougher competition for BrightSpring’s care and pharmacy staff, potentially increasing wage pressure or making roles harder to fill.
Fed Interest Rate Decision
Fed decisions track the cost of borrowing across the economy, which can change interest expense on BrightSpring’s variable-rate debt and the cash left for its pharmacy and care services.
Expected4.0%Last release4.0%
If it comes in above expectations
If rates rise more than expected, interest expense on BrightSpring’s debt that resets with rates may increase, leaving less operating cash for pharmacy and care services.
If it comes in below expectations
If rates fall more than expected, interest expense on BrightSpring’s debt that resets with rates may ease, leaving more operating cash for pharmacy and care services.
BrightSpring Health Services, Inc. earningsThis company
BrightSpring earns most of its revenue from its pharmacy business, and this report will show whether prescription volume and revenue per prescription are growing together and leaving more gross profit.
Read pharmacy revenue alongside prescriptions filled, then check whether gross profit keeps pace. Rising prescription volume and pharmacy revenue, with gross profit also increasing, would show that growth is not relying only on a richer mix of prescriptions and is converting into more dollars after direct costs. If revenue rises mainly because revenue per prescription is higher while prescription volume stalls or falls and gross profit lags, growth is more concentrated in drug mix or revenue per fill; the question is whether it is broadening the business.
Addus HomeCare Corp. earningsADUS
Addus HomeCare competes with BrightSpring in personal care and home health, and its report will show whether demand and revenue in those care services are holding up.
Read Addus’s service volume alongside revenue from personal care and home health. Growth in both would show demand and payment conditions supporting these types of care; weaker volume or revenue would mean less outside evidence of support for BrightSpring’s smaller Provider Services business. The companies have different service and payer mixes, so this is an industry comparison, not a result for BrightSpring itself.
JOLTs Job Openings (Sep)
JOLTS counts advertised job openings, giving a read on competition for nurses, pharmacists, therapists and caregivers that can affect BrightSpring’s staffing costs and ability to deliver pharmacy and care services.
Expected7.0MLast release7.079M
If it comes in above expectations
More openings than expected may mean stronger competition to hire the nurses, pharmacists, therapists and caregivers BrightSpring needs, potentially raising labor costs or limiting the care and pharmacy work it can deliver.
If it comes in below expectations
If the reading is below the 7.0M estimate, it is below the previous 7.079M. Fewer openings than expected may ease competition for BrightSpring’s nurses, pharmacists, therapists and caregivers, potentially helping it contain labor costs and keep services staffed.
Option Care Health, Inc. earningsOPCH
Option Care Health competes with BrightSpring for patients and payers in infusion care outside hospitals, and its report will show whether reimbursement for infusion drugs and services is squeezing that business.
Look at Option Care’s revenue from infusion drugs and services alongside what it says about reimbursement and the cost of providing care. If reimbursement covers costs and revenue holds up, payment conditions for infusion care look more supportive, suggesting less pressure on BrightSpring’s infusion business. If reimbursement weakens or service costs rise, leaving Option Care with less from its work, the market may also be making it harder for BrightSpring to turn infusion revenue into profit.
Humana Inc. earningsHUM
Humana is a payer for BrightSpring’s pharmacy services and manages drug benefits, so its report can show whether reimbursement rates and fees are helping or squeezing BrightSpring’s pharmacy profits.
Focus on Humana’s disclosed drug reimbursement rates and related fees, not just its total revenue. Better reimbursement or lower fees would leave BrightSpring more from the pharmacy services it provides; weaker rates or higher fees would squeeze that profit even if prescription volume did not fall. The takeaway is whether payer terms support the profitability of BrightSpring’s pharmacy business.
Non Farm Payrolls (Oct)
The monthly payrolls report counts jobs added or lost, indicating how much hiring competition BrightSpring may face for the nurses, pharmacists, therapists and caregivers needed to provide its services.
More jobs added may signal stronger hiring demand and tougher competition for BrightSpring’s care and pharmacy staff, potentially raising costs or constraining service delivery; fewer may ease recruitment pressure.
